Methyclothiazide And Deserpidine

   
Google
 
Web NewDrugInformation.com

Methyclothiazide And Deserpidine


Drug - Methyclothiazide And Deserpidine
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Deserpidine; Methyclothiazide
Multiple ingredients are in alphabetical order.

Strength - 0.5MG;5MG
The potency of the active ingredient(s), Deserpidine; Methyclothiazide. May repeat for multiple part products.

Applicant - WATSON LABS
The firm name holding legal responsibility for Methyclothiazide And Deserpidine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088452
The FDA assigned number to Methyclothiazide And Deserpidine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Methyclothiazide And Deserpidine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 10, 1984
The date Methyclothiazide And Deserpidine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Methyclothiazide And Deserpidine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Methyclothiazide And Deserpidine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Watson Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Methyclothiazide And Deserpidine.

Methyclothiazide And Deserpidine